US equities
|
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.96
▼-1.02%
TSLA
$378.73
▲+2.20%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
AAPL
$332.89
▼-0.24%
META
$741.90
▲+1.90%
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.96
▼-1.02%
TSLA
$378.73
▲+2.20%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
AAPL
$332.89
▼-0.24%
META
$741.90
▲+1.90%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Rain Enhancement Technologies Holdco, Inc. - Class A Common Stock
(NQ:
RAIN
)
0.7611
-0.0111 (-1.44%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Rain Enhancement Technologies Holdco, Inc. - Class A Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
The Law Offices of Frank R. Cruz Announces Investigation of Rain Oncology Inc. (RAIN) on Behalf of Investors
July 18, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Calling All Rain Oncology Inc. (RAIN) Investors: Contact Bronstein, Gewirtz & Grossman, LLC to Actively Participate in the Class Action Lawsuit!
July 18, 2023
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Rain Oncology Inc. (RAIN)
July 17, 2023
From
Robbins LLP
Via
Business Wire
NASDAQ:RAIN Investor Alert: Investigation over Possible Violations of Securities Laws by Rain Oncology Inc.
↗
June 09, 2023
San Diego, CA -- (SBWIRE) -- 06/09/2023 -- Rain Oncology Inc. is under investigation over potential securities laws violations in connection with certain financial statements.
Via
SBWire
Analyst Expectations for Rain Oncology's Future
↗
May 23, 2023
Via
Benzinga
Anticipation Builds For Rain Oncology's Phase 3 MANTRA Trial Results, Analyst Sees Promise
↗
May 12, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 5, 2023
↗
June 05, 2023
Via
Benzinga
Biotechs Zeroing In on Developing Breakthrough Therapeutics for Metastatic Breast Cancer
June 05, 2023
EQNX::TICKER_START (NASDAQ:ONCY),(NASDAQ:GILD),(NASDAQ:RAIN),(NASDAQ:CNSP),(NYSE:BMY) EQNX::TICKER_END
Via
FinancialNewsMedia
Recap: Rain Oncology Q1 Earnings
↗
May 11, 2023
Via
Benzinga
Why Guidewire Software Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
June 02, 2023
Gainers MultiMetaVerse Holdings Limited (NASDAQ: MMV) gained 236% to $3.1592 after the company announced it signed a non-binding term sheet to acquire an equity stake in Taomee group.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
June 02, 2023
Via
Benzinga
Why Lululemon Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
↗
June 02, 2023
Gainers Better Choice Company Inc. (NASDAQ: BTTR) shares rose 37% to $0.4522 in pre-market trading. Better Choice said it has selected Re:Amaze to assist in customer retention and acquisition for its...
Via
Benzinga
Over $4M Bet On Diversified Healthcare Trust? Check Out These 4 Stocks Under $5 Insiders Are Aggressively Buying
↗
June 02, 2023
The Dow Jones closed higher by around 150 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
June 01, 2023
Via
Benzinga
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Rain Oncology Inc. and Encourages Investors with Losses to Contact the Firm
May 25, 2023
From
The Schall Law Firm
Via
Business Wire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Rain Oncology Inc. and Encourages Investors with Losses to Contact the Firm
May 24, 2023
From
The Schall Law Firm
Via
Business Wire
Rain Oncology's Phase 3 Data Casts Doubt On Other Trials: Analyst Reevaluate Their Views
↗
May 23, 2023
Shares of Rain Oncology Inc (NASDAQ: RAIN) recovered in early trading on Tuesday, after having plummeted on disappointing cancer study data.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2023
↗
May 23, 2023
Via
Benzinga
Why Shares of Rain Oncology Are Plummeting Today
↗
May 22, 2023
The company released disappointing top-line results for its lead oncology therapy.
Via
The Motley Fool
Rain Oncology Shares Plummet: Company Discloses Disappointing Cancer Study Data After Delaying Readout
↗
May 22, 2023
Rain Oncology Inc (NASDAQ: RAIN) announced topline Phase 3 MANTRA data of milademetan in patients with
Via
Benzinga
Dow Tumbles 100 Points; Micron Technology Shares Plunge
↗
May 22, 2023
U.S. stocks traded mixed toward the end of trading, with the Dow Jones dropping over 100 points on Monday. The Dow traded down 0.36% to 33,306.30 while the NASDAQ rose 0.39% to 12,707.21. The S&P 500,...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
May 22, 2023
Via
Benzinga
Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
May 22, 2023
Gainers Greenhill & Co., Inc. (NYSE: GHL) shares jumped 116.4% to $14.67 after Mizuho announced it would acquire the company for $15 per share.
Via
Benzinga
Nasdaq Rises Over 50 Points; Greenhill Shares Spike Higher
↗
May 22, 2023
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining over 50 points on Monday. The Dow traded down 0.20% to 33,359.71 while the NASDAQ rose 0.47% to 12,717.37. The S&P...
Via
Benzinga
Why Is AVROBIO (AVRO) Stock Up 83% Today?
↗
May 22, 2023
AVROBIO (AVRO) stock is seeing massive gains on Monday as the company sells one of its gene therapies to Novartis (NVS).
Via
InvestorPlace
Why Is Greenhill (GHL) Stock Up 116% Today?
↗
May 22, 2023
Greenhill (GHL) stock is taking off on Monday thanks to news of a $550 million acquisition deal with Mizuho Financial Group (MFG).
Via
InvestorPlace
Why Is RAIN Stock Down 87% Today?
↗
May 22, 2023
Rain Oncology (RAIN) stock is taking a massive beating on Monday after the company revealed its latest clinical trial data.
Via
InvestorPlace
US Stocks Mixed; Nordic American Tankers Posts Upbeat Results
↗
May 22, 2023
U.S. stocks traded mixed this morning, with the Dow Jones trading slightly lower on Monday. Following the market opening Monday, the Dow traded down 0.01% to 33,422.94 while the NASDAQ rose 0.09% to...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
May 22, 2023
Via
Benzinga
Earnings Scheduled For May 11, 2023
↗
May 11, 2023
Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >